Centrus Energy ((LEU)) has held its Q4 earnings call. Read on for the main highlights of the call.
Claim 55% Off TipRanks
Trade LEU with leverageCentrus Energy’s latest earnings call struck a cautiously optimistic tone as management balanced strong strategic wins against tangible short‑term pressures. Executives emphasized record cash, a swelling backlog, and a landmark federal HALEU contract, while acknowledging softer uranium sales, margin compression in technical solutions, and execution risks that investors will need to track closely.
Full-Year Results Show Modest Growth and Solid Profitability
Centrus reported full-year 2025 revenue of $448.7 million, up 1.5% or $6.7 million from the prior year, with gross profit climbing about 5% to $117.5 million. Net income reached $77.8 million, underscoring that the core business remains profitable even as the mix shifts and some legacy revenue streams, such as uranium sales, fade.
SWU Performance Drives LEU Segment Margin Improvement
Separative work unit revenue surged 21% year over year, adding $51.9 million and reflecting a 23% increase in SWU volume sold, which supported better margins in the low enriched uranium segment. This SWU momentum is central to Centrus’ earnings power, helping offset weaker uranium revenues and giving the company more leverage as enrichment demand strengthens globally.
Backlog and Long-Term Demand Underpin Visibility
The company highlighted a total backlog of $3.8 billion extending out to 2040, with roughly $2.9 billion tied to LEU contracts, providing a long runway of future work. Within that, $2.3 billion is contingent and $2.1 billion sits under definitive agreements, showing strong demand but also reminding investors that a notable slice of future revenue still depends on clearing conditions and final documentation.
DOE HALEU Award Anchors Strategic Pivot
Management spotlighted being selected by the U.S. Department of Energy for a $900 million HALEU enrichment award that could ultimately top $1 billion with options, anchoring Centrus as a key player in advanced nuclear fuel. The base plan targets building out 12 metric tons of annual HALEU capacity, with the first cascade slated to come online in 2029, reinforcing a long-duration growth story tied to next-generation reactors.
Balance Sheet Fortified by Capital Raises and Cash Build
Centrus closed fiscal 2025 with approximately $2.0 billion in unrestricted cash, giving it significant firepower to fund its HALEU expansion and broader capital plan. The company raised $533.6 million through at-the-market stock offerings, including $390.4 million at an average price of $269.21 per share, and completed an oversubscribed convertible note deal, albeit with the dilution and future obligations that come with it.
Commercial and Operational Progress Broadens Strategic Footprint
The call highlighted the launch of commercial centrifuge manufacturing and key DOE waivers that allow continued import of LEU for committed 2026–2027 deliveries, supporting near-term contract fulfillment. Centrus also signed an EPC agreement with Fluor for its Piketon project, uplisted to the NYSE, and entered MOUs with foreign partners like KHMP and POSCO International to validate potential cross-border investment in its fuel strategy.
Technical Solutions Revenue Rises Alongside HALEU Milestones
Technical solutions revenue climbed 11% in 2025 to $102.5 million, reflecting steady demand for the company’s engineering and contract work. Centrus completed key phase two milestones under its HALEU operations contract, delivering 900 kilograms of HALEU UF6 and surpassing one metric ton produced for the DOE, demonstrating tangible operational progress in a market still early in commercialization.
2026 Guidance and Execution Milestones Emphasize Build-Out
For 2026, Centrus guided to revenue of $425–$475 million, with a midpoint of $450 million roughly flat with 2025, while planning to deploy $350–$500 million in capital, including prepayments. The company aims to add at least 150 net new employees, issue the first certified-for-construction work package in Piketon, and have most Ohio construction partners mobilized by year-end, marking a pivot from planning to large-scale execution.
Uranium Revenue Decline Highlights Mix Shift
Uranium revenue dropped 54% to $55.6 million, largely due to the absence of a major one-time uranium sale recorded in 2024, and underscoring a shift away from opportunistic uranium trading toward enrichment and services. While the comparison is tough, management framed the decline as largely expected and consistent with the company’s strategic reorientation toward higher-value activities like HALEU.
Technical Solutions Margin Hit by HALEU Cost Overruns
Despite higher sales, technical solutions gross profit sank 66% to just $6.0 million, pressured by a $22.8 million cost increase on the HALEU operations contract. Phase-two work remains “undefinitized” and not yet fee-bearing, meaning Centrus is absorbing costs ahead of final contract terms, a dynamic that weighs on short-term margins but is positioned as a necessary step toward long-term HALEU leadership.
Russian Shipment Delay Weighs on 2025 Margins
A permitted fourth-quarter shipment from Russia did not arrive as planned and was pushed into 2026, forcing Centrus to rely on higher-cost material and driving up its average SWU cost. Management said the delay hurt 2025 gross margin and net income, illustrating the company’s exposure to complex international supply chains even as it tries to localize and secure critical fuel sourcing.
Contingent Backlog and Contract Timing Add Uncertainty
Roughly $2.3 billion of LEU backlog remains contingent, with $200 million of that still awaiting final definitive agreements, leaving part of future revenue dependent on counterparties clearing hurdles. While the overall backlog is substantial, investors will want to monitor how quickly these contingencies are removed and how firm the revenue profile becomes as contracts move to binding status.
Nonrecurring and Transition Costs Pressure 2025 Results
The company recorded about $3.6 million in nonrecurring general and administrative expenses and $1.1 million tied to CFO transition and voluntary tax withholding, which modestly weighed on 2025 earnings. Management framed these as one-time items associated with organizational changes and equity-related tax decisions, rather than structural increases in overhead.
Execution and Timing Risks Loom Over Ambitious Build-Out
Centrus underscored that its HALEU and centrifuge expansion faces significant execution risk, including long-lead equipment procurements, supplier readiness for national security-grade work, and the challenge of bringing new cascades online by 2029. These timing and supply-chain factors will be critical in determining whether the company can convert its large award book and cash balance into durable, higher-margin earnings.
Forward-Looking Outlook Centered on HALEU and Capital Deployment
Management’s 2026 outlook calls for flat revenue around $450 million but sharply higher capital deployment of $350–$500 million as the HALEU build-out ramps, supported by about $2.0 billion in cash and a $3.8 billion backlog. The company continues to target 12 metric tons per year of HALEU capacity with the first new centrifuge cascade expected online in 2029, while hiring and construction milestones in Oak Ridge and Piketon are set as key markers of execution progress.
Centrus Energy’s earnings call painted a picture of a company in transition, trading near-term margin and contract complexity for the chance to dominate a future HALEU market backed by federal support. With a fortified balance sheet, deep backlog, and clear growth roadmap, the upside appears significant, but investors will need to watch contract conversion, project execution, and supply-chain stability to gauge how much of that promise turns into sustainable earnings.